Skip to main content
Clinical Trials/JPRN-UMIN000011771
JPRN-UMIN000011771
Not yet recruiting
Phase 4

Diagnostic performance of contrast-enhanced CT, Diffusion-weighted MRI and FDG-PET in pleural thickening -Prospective study- - Diagnostic performance of contrast-enhanced CT, Diffusion-weighted MRI and FDG-PET in pleural thickening -Prospective study

Saitama Medical University International Medical Center0 sites100 target enrollmentSeptember 16, 2013
ConditionsMesothelioma

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Mesothelioma
Sponsor
Saitama Medical University International Medical Center
Enrollment
100
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 16, 2013
End Date
December 31, 2018
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Patients in whom pathological diagnosis was made 2\) Patients who underwent invasive treatment 3\) Patients for whom the investigator or subinvestigator(s) judges their participation in the clinical trial to be inappropriate 4\) Patients in whom MRI examination is contraindicated (e.g., use of a pacemaker) 5\) Patients in whom iodine\-based and Gd\-based contrast media are contraindicated (e.g., patients with a history of hypersensitivity to these contrast media)

Outcomes

Primary Outcomes

Not specified

Similar Trials